한빛사
>
한빛사논문
한빛사논문
- 조회261
Clin. Mol. Hepatol., Oct 2024, 30 (4) | https://doi.org/10.3350/cmh.2024.0346
[Editorial] Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure: Editorial on "Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients"
Hae Lim Lee 1,2, Jeong Won Jang 1,2
1Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
2The Catholic University Liver Research Center, Seoul, Korea.
Corresponding author : Jeong Won Jang
Abstract
No abstract available
논문정보
- Editorial
- 2024년 10월 (BRIC 등록일 2024-11-06)
- 국내 연구진
- 의약학 > 의약학 기타
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
